Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ALLENDALE, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Acuitive Technologies® commercializes Citregraft™, with its first use in a surgical case, performed on November 4th, 2025. Bone graft substitutes...
-
ALLENDALE, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Acuitive Technologies (Acuitive), a leading orthopedic medical device company focused on complex soft tissue repair and regeneration, announces...
-
Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.
-
ALLENDALE, N.J., September 27, 2023 -- Acuitive Technologies announced the FDA 510(k) Clearance of CITRELOCK DUO Fixation Device for biceps tenodesis
-
Citrelock® Differentiated Biomaterial and Design Features ALLENDALE, N.J., June 29, 2023 (GLOBE NEWSWIRE) -- Acuitive Technologies, Inc. (Acuitive) today announced the first surgical use of its...
-
ALLENDALE, N.J., March 13, 2023 (GLOBE NEWSWIRE) -- Acuitive Technologies announced that Vince Forlenza and Gary Fischetti will join their Board of Directors. Both bring decades of medical...